Wells Fargo analyst Blaine Heck maintains Douglas Emmett (NYSE:DEI) with a Overweight and lowers the price target from $38 to $28.
Wells Fargo Maintains Overweight on Douglas Emmett, Lowers Price Target to $28
Wells Fargo analyst Blaine Heck maintains Douglas Emmett (NYSE:DEI) with a Overweight and lowers the price target from $38 to $28.
Related Posts
Ollie’s Bargain Outlet Holdings Announces Hiring Of Rob Helm To The Position Of Senior Vice President And Chief Financial Officer, Effective Immediately
Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) announced the hiring of Rob Helm to the position of Senior Vice President and Chief Financial Officer, effective immediately. Rob will report to John Swygert,
Stifel Maintains Hold on Snap, Lowers Price Target to $9
Stifel analyst Mark Kelley maintains Snap (NYSE:SNAP) with a Hold and lowers the price target from $14 to $9.
FDA’s AdComm Panel Favors Innoviva’s Drug For Multidrug-Resistant Bacterial Infections
The FDA’s Antimicrobial Drugs Advisory Committee unanimously voted 12-0 in support of approval of Innoviva Inc’s (NASDAQ:INVA) sulbactam-durlobactam for hospital-acquired bacterial pneumonia…